CHRONOS-3: Randomized Phase III study of copanlisib plus rituximab vs rituximab/placebo in relapsed indolent non-Hodgkin lymphoma (iNHL).

---

Matasar M. J., Capra M., ÖZCAN M., Lv F., Li W., Yanez E., ...Daha Fazla

CANCER RESEARCH, cilt.81, sa.13, 2021 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Özet
• Cilt numarası: 81 Sayı: 13
• Basım Tarihi: 2021
• Dergi Adı: CANCER RESEARCH
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, BIOSIS, Biotechnology Research Abstracts, CAB Abstracts, Chemical Abstracts Core, EMBASE, Gender Studies Database, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database
• Ankara Üniversitesi Adresli: Evet